Literature DB >> 4364904

Endogenous C-type virus of a mouse cell line and its defectiveness.

H Yoshikura, Y Hirokawa.   

Abstract

MLg cells originating from a newborn ddY mouse began to release C-type virus by treatment with 5-iodo-2'-deoxyuridine (5 mug/ml) for 48 h, or spontaneoulsy after prolonged cultivation. The data indicated the presence of three categories of the viruses spontaneously induced, i.e., virus equipped with the abilities of infecting and transforming the S+L- C182 cells, virus which can infect C182 cells but is unable to transform C182 cells, and virus which cannot infect nor transform the C182 cells, but is positive for the XC test. The type of the virus produced depended upon the cell clone. With the advance in the passage level, the cell population was dominated by the cells producing, uniquely, the last category of the virus.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4364904      PMCID: PMC355451     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus.

Authors:  W P Rowe; J W Hartley; M R Lander; W E Pugh; N Teich
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

2.  Infectious but non-leukemogenic Friend leukemia virus obtained after prolonged cultivation in vitro.

Authors:  H Yoshikura; Y Hirokawa; Y Ikawa; H Sugano
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

3.  Production of friend leukemia virus in a mouse lung cell line.

Authors:  H Yoshikura; Y Hirokawa; M Yamada; H Sugano
Journal:  Jpn J Med Sci Biol       Date:  1967-06

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Protective effect of specific immunization in Rauscher leukemia.

Authors:  G Barski; J K Youn
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

6.  Attenuation of the Rauscher murine leukemia virus through serial passages in tissue culture.

Authors:  B S Wright; J C Lasfargues
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

7.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

8.  Demonstration of biological activity of a murine leukemia virus of New Zealand black mice.

Authors:  J A Levy; T Pincus
Journal:  Science       Date:  1970-10-16       Impact factor: 47.728

9.  Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine.

Authors:  D R Lowy; W P Rowe; N Teich; J W Hartley
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

10.  Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells.

Authors:  S A Aaronson; G J Todaro; E M Scolnick
Journal:  Science       Date:  1971-10-08       Impact factor: 47.728

View more
  4 in total

1.  Rescue and transmission of a replication-defective variant of moloney murine leukemia virus.

Authors:  A Rein; B M Benjers; B I Gerwin; R H Bassin; D R Slocum
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

2.  Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: implications for iron metabolism.

Authors:  Ping La; Guang Yang; Phyllis A Dennery
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

3.  Variants of N-tropic leukemia virus derived from BALB/c mice.

Authors:  N Hopkins; P Jolicoeur
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

4.  Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.

Authors:  Li Zhong; Jonathon Roybal; Raghothama Chaerkady; Wan Zhang; Kuicheon Choi; Cristina A Alvarez; Hai Tran; Chad J Creighton; Shaoyu Yan; Robert M Strieter; Akhilesh Pandey; Jonathan M Kurie
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.